Flu is a serious health, medical, and economic problem, but no therapy is yet available that
has satisfactory results and reduces the occurrence of these problems. Nearly 20 years after …

Despite aggressive efforts on containment measures for the coronavirus disease 2019
(COVID-19) pandemic around the world, severe acute respiratory syndrome coronavirus 2 …

Summary Background Neuraminidase inhibitors (NAIs) are considered the standard of care
for hospitalised patients with influenza. We aimed to test whether combining the cap …

This technical report accompanies the recommendations of the American Academy of
Pediatrics for the routine use of influenza vaccine and antiviral medications in the prevention …

This technical report accompanies the recommendations of the American Academy of
Pediatrics for the routine use of influenza vaccine and antiviral medications in the prevention …

SUMMARY OF RECENT INFLUENZA SEASONS IN THE UNITED STATES 2017–2018,
2018–2019, and 2019–2020 Influenza Seasons The 2017–2018 influenza season was the …

Influenza poses a significant burden on society and health care systems. Although antivirals
are an integral tool in effective influenza management, the potential for the emergence of …

This technical report accompanies the recommendations of the American Academy of
Pediatrics for the routine use of influenza vaccine and antiviral medications in the prevention …

Prompt antiviral treatment has the potential to reduce influenza virus transmission to close
contacts, but rigorous data on the magnitude of treatment effects on transmission are limited …

Influenza B viruses cause significant morbidity and mortality, particularly in children, but the
awareness of their impact is often less than influenza A viruses partly due to their lack of …